蓝鲸新闻4月2日讯，2026年4月1日，国家药监局官网发布通告，艾尔建医疗器械（上海）有限公司报告，因销往乌兹别克斯坦的某批次含利多卡因注射用交联透明质酸钠凝胶（商品名：Juvéderm VOLBELLA with Lidocaine，注册证号：国械注进20213130109）在运输途中发生超温，可能影响产品稳定性与安全性，艾尔建ALLERGAN对该产品实施主动召回，召回级别为二级。本次召回涉及特定批次，具体型号、规格及批号详见《医疗器械召回事件报告表》。监管部门已要求企业立即通知相关经营使用单位，暂停销售并召回相关产品。消费者如已购买该批次产品，建议停止使用并联系经销商或企业获取进一步处理信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.